Covid-19: As lab execs sell shares worth millions, questions ariseThis combination of file pictures shows signs for the Pfizer and Moderna pharmaceutical companies, both in Cambridge, Massachusetts; executives at both, as well as at Novavax, have raised questions by selling shares worth millions amid the pandemic. On the very day that pharmaceutical giant Pfizer announced preliminary data showing its vaccine was 90% effective against the coronavirus, its chief executive Albert Bourla sold shares worth $5.6 million. Under the same rules, several Moderna officials have sold shares worth more than $100 million in recent months. Moderna shares have soared from $19 at the beginning of the year to a current level of $90. When a top executive needs to sell shares to pay for a yacht, a new house or his children's education, the public rarely is aware of it.

Source: Bangkok Post November 15, 2020 05:26 UTC